Genetic Technologies Limited (GENE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Genetic Technologies Limi...

    NASDAQ: GENE · Real-Time Price · USD
    0.77
    0.01 (0.65%)
    At close: Nov 14, 2024, 10:00 PM

    Genetic Income Statement

    Financials in AUD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 7.66M 10.35M 6.79M 120.55K
    Cost of Revenue
    		 3.76M 4.34M 321.22K 361.03K
    Gross Profit
    		 3.9M 6.01M 6.47M -240.47K
    Operating Income
    		 -12.21M -10.42M -7.54M -7.42M
    Interest Income
    		 119.51K 220.16K 36.26K 62.39K
    Pretax Income
    		 -12.02M -11.91M -7.16M -7.08M
    Net Income
    		 -12.02M -11.75M -7.13M -7.08M
    Selling & General & Admin
    		 12.83M 10.8M 4.07M 5.28M
    Research & Development
    		 752.75K 1.28M 705.51K 3.11M
    Other Expenses
    		 2.54M 45.72K -1.49M 116.27K
    Operating Expenses
    		 16.11M 18.11M 3.11M 7M
    Interest Expense
    		 51.62K 29.52K 15.21K 14.05K
    Selling & Marketing Expenses
    		 2.61M 2.95M 1.89M 1.12M
    Cost & Expenses
    		 16.21M 22.45M 3.43M 7.36M
    Income Tax Expense
    		 n/a 158.33K -32.13K n/a
    Shares Outstanding (Basic)
    		 4.61M 3.38M 3.07M 2.85M
    Shares Outstanding (Diluted)
    		 4.61M 3.38M 3.07M 2.85M
    EPS (Basic)
    		 -2.73 -3.6 -2.32 -2.48
    EPS (Diluted)
    		 -2.73 -3.6 -2.32 -2.48
    EBITDA
    		 -11.43M -11.2M -7.2M -7.06M
    EBIT
    		 -11.97M -11.88M -7.15M -7.06M
    Depreciation & Amortization
    		 534.89K 676.58K 578.67K 478.22K

    Add to Watchlist